4th Quarter - Report

BAYER CORPORATION (CONSOLIDATED REPORT) for BAYER CORPORATION (CONSOLIDATED REPORT)

Firm
Client
Income
—
Expenses
$1,000,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

12 issue areas, each in the filer's own words, with who lobbied on it and where.

Homeland Security HOM

Monitor the implementation of the FY2013 Continuing Appropriations Act, P.L. 113-6.

LobbyistCovered position, as disclosed
DONNA STEPHENS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Tariff (miscellaneous tariff bills) TAR

H.R.2708, To amend the Harmonized Tariff Schedule of the United States to modify temporarily certain rates of duty, and for other purposes. Provisions related to specific tariffs.

LobbyistCovered position, as disclosed
MATTHEW GRIERSON PERIN —
JEAN D REIMERS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2708 (113th)

Copyright/Patent/Trademark CPT

H.R. 3309, the Innovation Act. Monitored legislative and federal activity related to intellectual property protection.

LobbyistCovered position, as disclosed
JULIE CORCORAN —
THOMAS B LILBURN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3309 (113th)

Banking BAN

S1106, Sensible Accounting to Value Energy Act of 2013. All provisions pertaining to sensible accounting to value energy related to mortgages means tested by energy effeciency.

LobbyistCovered position, as disclosed
DAKOTAH SMITH —
JULIANE H VAN EGMOND —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Medicare/Medicaid MMM

S. 1871, SGR Repeal and Medicare Beneficiary Access Act of 2013. Need for tranparency on the CMS preventative maintenance directive for medical equipment.

LobbyistCovered position, as disclosed
THOMAS B LILBURN —
ROBERT D THOMAS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1871 (113th)

Chemicals/Chemical Industry CHM

S696, Safe Chemicals Act of 2013. Provisions pertaining to chemical risk management. S1009, Chemical Safety Improvement Act. Provisions pertaining to chemical risk management.

LobbyistCovered position, as disclosed
DAKOTAH SMITH —
JULIANE H VAN EGMOND —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Agriculture AGR

S. 954, Agriculture Reform, Food, and Jobs Act of 2013. Provisions related to National Pollutant Elimination System (NPDES) permits, Endangered Species, Winter Wheat Cereals Project and Pollinators.H.R. 1947, Federal Agriculture Reform and Risk Management Act of 2013. Provisions related to National Pollutant Elimination System (NPDES) permits, Endangered Species, Biotechnology, Winter Wheat Cereals Project and Pollinators. S. 809/H.R. 1699, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling. H.R.2692, Saving America's Pollinators Act of 2013. Provisions related to suspension of pesticide registrations. H.R. 2642, Federal Agriculture Reform and Risk Management Act 2013.

LobbyistCovered position, as disclosed
MATTHEW GRIERSON PERIN —
JEAN D REIMERS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2692 (113th), S. 954 (113th), S. 809 (113th), H.R. 1947 (113th), H.R. 2642 (113th), H.R. 1699 (113th)

Taxation/Internal Revenue Code TAX

Monitor legislative and federal activity related to the corporate R&D tax and renewal of tax credits 25C, 179C, and 45L tax credits on energy efficiency

LobbyistCovered position, as disclosed
DAKOTAH SMITH —
JULIANE H VAN EGMOND —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

H.R. 1150, Title: To amend the Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antimicrobials used in the treatment of human and animal diseases. Title II, General provisions in the bill. S. 1256, Preventing Antibiotic Resistance Act of 2013. A bill to amend the Federal Food, Drug, and Cosmetic Act to preserve the effectiveness of medically important antimicrobials used in the treatment of human and animal diseases.S.959/HR 3204, Pharmaceutical Compounding Quality and Accountability Act. General provisions of the bill. HR 2725, Food and Drug Administration Safety Over Sequestration Act of 2013. Monitor the implementation of the Patient Protection and Affordable Care Act, P.L. 111-148.

LobbyistCovered position, as disclosed
JULIE CORCORAN —
THOMAS B LILBURN —
DONNA STEPHENS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1150 (113th), S. 1256 (113th), S. 959 (113th), H.R. 3204 (113th), H.R. 2725 (113th)

Energy/Nuclear ENG

S761, Energy Savings and Industrial Competitiveness Act of 2013. All measures related to energy efficiency. S1020, All-Of-The-Above Federal Building Energy Conservation Act of 2013. All measures pertaining to requirements to eliminate fossil fuels by 2030.S1392/ HR 1616, Energy Savings and Industrial Competitiveness Act of 2013 - all provisions pertaining to the Shaheen Portman Act S. 761 regarding grants to federal facilities wishing to improve energy efficiency and to update the national model building standards

LobbyistCovered position, as disclosed
DAKOTAH SMITH —
JULIANE H VAN EGMOND —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1616 (113th), S. 761 (113th)

Education EDU

S 553/HR 1125, Veterinary Medicine Loan Repayment Program Enhancement Act.

LobbyistCovered position, as disclosed
DONNA STEPHENS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1125 (113th)

Pharmacy PHA

HR 3204, Drug Quality and Security Act. Monitored legislative and federal activity related to drug distribution and safety and pharmacy drug compounding.

LobbyistCovered position, as disclosed
THOMAS B LILBURN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3204 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.